Durvalumab/Osimertinib Mesylate | m-entrepreneurship.com

Product Name :
Durvalumab/Osimertinib Mesylate

Search keywords :
Osimertinib (mesylate)

drugId :
null

Target Vo:
Programmed death-ligand 1

Target Vo Short Name :
PD-L1

Moa_Name:
Programmed death-ligand 1 blockers

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Medimmune Llc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Vadastuximab Data Sheet
Beclin 1 Rabbit mAb supplier
IKK gamma Antibody: IKK gamma Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 48 kDa, targeting to IKK gamma. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts